Current Protein Identity:Q30069
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 4Z7U S13 complex Deposited 2015-04-08 | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;140 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 7.5, 15% PEG8000
|
Resolution 2.70 Å R-free 0.220 |
| 4Z7U S13 complex Deposited 2015-04-08 | Assembly 2 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain C
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;140 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 7.5, 15% PEG8000
|
Resolution 2.70 Å R-free 0.220 |
| 4Z7V L3-12 complex Deposited 2015-04-08 | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;80 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 6.5, 16% PEG8000
|
Resolution 2.65 Å R-free 0.226 |
| 4Z7V L3-12 complex Deposited 2015-04-08 | Assembly 2 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain C
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;80 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 6.5, 16% PEG8000
|
Resolution 2.65 Å R-free 0.226 |
| 4Z7W T316 complex Deposited 2015-04-08 | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.32 M (NH4)2SO4, 0.1 M HEPES pH 7.8, 20% PEG3350
|
Resolution 2.89 Å R-free 0.247 |
| 4Z7W T316 complex Deposited 2015-04-08 | Assembly 2 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain C
1–184(184 aa)
Fragment:UNP residues 1-184
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 SO4 SULFATE ION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.32 M (NH4)2SO4, 0.1 M HEPES pH 7.8, 20% PEG3350
|
Resolution 2.89 Å R-free 0.247 |
| 6DFX human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide Deposited 2018-05-15 | Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain A
3–184(182 aa)
|
Not recorded | EDO 1,2-ETHANEDIOL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;278 K;10% PEG 8000, 100mM cacodylate pH6.2, 400mM NaCl
|
Resolution 2.03 Å R-free 0.217 |
| 6DFX human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide Deposited 2018-05-15 | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain D
3–184(182 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;278 K;10% PEG 8000, 100mM cacodylate pH6.2, 400mM NaCl
|
Resolution 2.03 Å R-free 0.217 |
| 6XC9 Immune receptor complex Deposited 2020-06-08 | Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain A
1–184(184 aa)
|
Mutation:I72C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;13% PEG 8000, 0.2 M Potassium dihydrogen phosphate
|
Resolution 2.40 Å R-free 0.219 |
| 6XC9 Immune receptor complex Deposited 2020-06-08 | Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain F
1–184(184 aa)
|
Mutation:I72C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 5 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;13% PEG 8000, 0.2 M Potassium dihydrogen phosphate
|
Resolution 2.40 Å R-free 0.219 |
| 6XCO Immune receptor complex Deposited 2020-06-08 | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain A
1–184(184 aa)
|
Mutation:I72C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 GOL GLYCEROL × 6 CAC CACODYLATE ION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293.15 K;0.1 M calcium acetate, 0.1 M sodium cacodylate pH 5.5, 13% polyethylene glycol (PEG) 20,000
|
Resolution 2.90 Å R-free 0.247 |
| 6XCP Immune receptor complex Deposited 2020-06-08 | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain A
1–184(184 aa)
|
Mutation:I72C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 1 PO4 PHOSPHATE ION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;13% PEG 8000, 0.2M Potassium dihydrogen phosphate
|
Resolution 3.30 Å R-free 0.268 |
| 8VCX Human TCR A2.13 in complex with DQ8-InsCpep Deposited 2023-12-14 | Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–185(185 aa)
|
Mutation:C75I | PO4 PHOSPHATE ION × 1 GOL GLYCEROL × 5 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Potassium sodium tartrate, 24% PEG 3350
|
Resolution 2.59 Å R-free 0.238 |
| 8VCY Human TCR A2.13 in complex with DQ8-InsC8-15NPY Deposited 2023-12-14 | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–184(184 aa)
|
Mutation:I75C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 5 PO4 PHOSPHATE ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Potassium sodium tartrate, 14% PEG 20,000 with seeding C8 silver bullet (Hampton Research)
|
Resolution 2.60 Å R-free 0.225 |
| 8VD0 Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 Deposited 2023-12-14 | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain A
1–185(185 aa)
|
Mutation:I75C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 4 PO4 PHOSPHATE ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 15% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.40 Å R-free 0.220 |
| 8VD0 Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 Deposited 2023-12-14 | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count |
Chain F
1–185(185 aa)
|
Mutation:I75C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 GOL GLYCEROL × 8 PO4 PHOSPHATE ION × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 15% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.40 Å R-free 0.220 |
| 8VD2 Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 Deposited 2023-12-14 | Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count |
Chain A
1–185(185 aa)
|
Mutation:I75C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M potassium dihydrogen phosphate (KH2PO4), 15% w/v PEG 20,000 with seeding and additive 30 mM MnCl2
|
Resolution 2.90 Å R-free 0.259 |
| 8VDD Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 Deposited 2023-12-14 | Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count |
Chain A
1–184(184 aa)
|
Mutation:I75C | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 GOL GLYCEROL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 14% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.60 Å R-free 0.280 |
| 8VDU Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 Deposited 2023-12-17 | Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count |
Chain A
1–184(184 aa)
Chain D
1–184(184 aa)
Chain G
1–184(184 aa)
Chain J
1–184(184 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 PEG DI(HYDROXYETHYL)ETHER × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Monopotassium phosphate, 17% PEG 8K
|
Resolution 3.50 Å R-free 0.246 |